HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
IMNN
Imunon, Inc.
There isn't enough reported data to score IMNN yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
IMNN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Unavailable |
IMNN's revenue is currently stable, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
IMNN PE Valuation
IMNN has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
IMNN Forward outlook
There aren't enough analyst estimates for IMNN to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
IMNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$5.26 | +$6.00 |
| Q2 2026 | -$5.78 | +$9.42 |
| Q1 2026 | -$7.39 | +$13.31 |
| Q4 2025 | -$10.75 | +$13.55 |
| Q3 2025 | -$11.26 | +$16.79 |
| Q2 2025 | -$15.20 | +$13.30 |
| Q1 2025 | -$20.70 | +$9.30 |
| Q4 2024 | -$24.30 | +$8.10 |
IMNN has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus flat for IMNN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
IMNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2022 | $125K | 0% |
| Q3 2022 | $125K | 0% |
| Q2 2022 | $125K | 0% |
| Q1 2022 | $125K | 0% |
| Q4 2021 | $125K | 0% |
| Q3 2021 | $125K | 0% |
| Q2 2021 | $125K | 0% |
| Q1 2021 | $125K | 0% |
IMNN's revenue has held roughly level: $125,000 last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2022 | -5541% | -1149 points |
| Q3 2022 | -4940% | -890 points |
| Q2 2022 | -4783% | -726 points |
| Q1 2022 | -4674% | -367 points |
| Q4 2021 | -4393% | -558 points |
| Q3 2021 | -4049% | -722 points |
| Q2 2021 | -4057% | -244 points |
| Q1 2021 | -4307% | -494 points |
IMNN's operating margin was −5541% last quarter, down 1149 points from the same quarter a year ago, near the bottom of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
IMNN has the stronger cash trend. Its trailing FCF is up 22% versus its history, compared with HIMS at down 84%.
IMNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3.2M | +$1.2M |
| Q4 2025 | -$3.7M | +$775.2K |
| Q3 2025 | -$4.4M | -$382.7K |
| Q2 2025 | -$3M | +$1.5M |
| Q1 2025 | -$3.1M | +$2.8M |
| Q4 2024 | -$4.4M | -$663.6K |
| Q3 2024 | -$4.1M | +$654.4K |
| Q2 2024 | -$4.5M | +$2.3M |
IMNN has burned cash in almost every quarter: −$14M over the past year, against −$16M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over IMNN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
IMNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +715K shares |
| 1 year | +366% | +4.7M shares |
| 3 years | +977% | +5.4M shares |
| 5 years | +3823% | +5.8M shares |
IMNN has 6M diluted shares, up 366% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
IMNN Net Leverage
IMNN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
IMNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.1 | Oversold |
| Stochastic | 8.5 | Oversold |
IMNN's weekly RSI is 25 (oversold) and its Stochastic is 9 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
IMNN PE vs Healthcare Sector
IMNN has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
IMNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.05 | 39% below |
| 20 week MA | $1.41 | 55% below |
| 50 week MA | $2.36 | 73% below |
| 100 week MA | $6.65 | 90% below |
| 200 week MA | $11.7 | 95% below |
IMNN is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over IMNN on returns for 2026, with the stronger performance.
IMNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $366.8 | $166.5 | -55% |
| 2021 | $166.5 | $139.5 | -16% |
| 2022 | $139.5 | $20.0 | -86% |
| 2023 | $20.0 | $10.2 | -49% |
| 2024 | $10.2 | $11.9 | +17% |
| 2025 | $11.9 | $3.15 | -74% |
| 2026 YTD | $3.15 | $0.64 | -80% |
IMNN has finished lower in five of the last six years. It's down 80% so far in 2026.